VanEck Biotech ETF $BBH Shares Sold by Miller Investment Management LP

Miller Investment Management LP trimmed its holdings in shares of VanEck Biotech ETF (NASDAQ:BBH) by 11.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,432 shares of the company’s stock after selling 10,373 shares during the quarter. VanEck Biotech ETF accounts for about 1.3% of Miller Investment Management LP’s portfolio, making the stock its 17th largest position. Miller Investment Management LP’s holdings in VanEck Biotech ETF were worth $12,482,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in BBH. Jones Financial Companies Lllp lifted its position in VanEck Biotech ETF by 5,710.9% during the first quarter. Jones Financial Companies Lllp now owns 152,070 shares of the company’s stock valued at $23,925,000 after purchasing an additional 149,453 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in shares of VanEck Biotech ETF by 8.3% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 22,361 shares of the company’s stock valued at $3,518,000 after buying an additional 1,705 shares during the last quarter. Bleakley Financial Group LLC acquired a new position in shares of VanEck Biotech ETF in the 2nd quarter valued at about $2,909,000. Altfest L J & Co. Inc. boosted its stake in shares of VanEck Biotech ETF by 15.1% in the first quarter. Altfest L J & Co. Inc. now owns 7,661 shares of the company’s stock worth $1,205,000 after buying an additional 1,007 shares during the last quarter. Finally, Wealthfront Advisers LLC boosted its stake in shares of VanEck Biotech ETF by 25.1% in the first quarter. Wealthfront Advisers LLC now owns 7,252 shares of the company’s stock worth $1,141,000 after buying an additional 1,455 shares during the last quarter. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Trading Down 0.5%

Shares of BBH stock opened at $180.74 on Friday. VanEck Biotech ETF has a twelve month low of $135.34 and a twelve month high of $182.66. The stock has a 50 day moving average of $172.02 and a 200 day moving average of $161.01.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.